Transplant rejection occurs when the immune system of a transplant recipient attacks and rejects the donated organ or tissue. There are four types of grafts based on genetic relationship between donor and recipient: autografts, isografts, allografts, and xenografts. For successful transplantation without rejection, matching major histocompatibility locus antigens between donor and recipient is important. Rejection can be avoided by tissue typing to ensure donor and recipient tissues are as similar as possible.
History
Introduction
Classification of grafts
The Immunology of Allogeneic Transplantation
Genetics of graft rejection
Types of rejection
Recognition of Alloantigens
Effector Mechanisms of Allograft Rejection
Prevention of graft rejection
Graft versus host reaction
History
Introduction
Classification of grafts
The Immunology of Allogeneic Transplantation
Genetics of graft rejection
Types of rejection
Recognition of Alloantigens
Effector Mechanisms of Allograft Rejection
Prevention of graft rejection
Graft versus host reaction
A. There are three types of immunological disorders
1. Hypersensitivity
2. Autoimmune disease
3. Immunodeficiency
B. Hypersensitivity reactions to usually harmless substances are often called allergies or allergic reactions
A. There are three types of immunological disorders
1. Hypersensitivity
2. Autoimmune disease
3. Immunodeficiency
B. Hypersensitivity reactions to usually harmless substances are often called allergies or allergic reactions
Immunology of Transplantation and Rejection A. Rakha
This file gives info about transplantation and the immunological problem like tissue rejection. MHC role in transplantation, laws, and types of tissue transplantation. Explains all kinds of tissue rejection and source of tissue. Some immunological terms plus transplantation history, it also includes the genetic basis of Transplantation. Hope it's helpful
Involves the principles of organ transplantation - basics of immunology and organ donation, preservation and eventual transplantation in the recipient.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. What is Transplant rejection?
• Transplant rejection is process in which the
transplanted tissue (of donor) is rejected by
the recipient's immune system and may result
in fatal illness if not treated/removed early.
3. Based on genetic relationship between donor and
recipient there are four types of Grafting
methods:
1. Autografts are grafts in which the donor and
recipient is the same individual.
2. Isografts are grafts between the donor and
recipient of the same genotype.
3. Allografts are those in which the donor is of the
same species but of a different genotype.
4. Xenografts are those in which the donor is of a
different species from that of the recipient.
4.
5. • For any successful tissue transplant without
immunological rejection, matched Major
Histocompatibility Locus Antigens (HLA)
between the donor and recipient are of
paramount importance.
• The greater the genetic disparity between
donor and recipient in HLA system, the
stronger and more rapid will be the rejection
reaction.
6. • All types of grafts have been performed in
human beings but xenografts have been found
to be rejected invariably due to genetic
disparity.
• Most commonly practiced grafting are:
- Skin grafting
- Kidney
- Bone marrow transplantation.
7. Exceptions in Rejections:
• Cornea transplants are rarely rejected because
the cornea has no blood supply.
• Also, transplants from one identical twin to
another are almost never rejected.
8. Graft versus Host Reaction
• In some cases esp. when the transplanted
tissue is bone marrow, a peculiar illness arises
besides rejection of the transplanted bone
marrow called GRAFT Vs HOST REACTION.
• The intensity of GVH reaction depends upon
the extent of genetic disparity between the
donor and recipient.
9. • The clinical features of Graft Vs Host reaction
include:
- Fever,
- Weight Loss,
- Anaemia,
- Dermatitis,
- Diarrhoea,
- Intestinal Malabsorption,
- Pneumonia,
- Hepatosplenomegaly.
10. MECHANISMS OF GRAFT REJECTION
• Except for autografts and isografts, an
immune response against allografts is
inevitable/unavoidable.
• The development of immunosuppressive
drugs has made the survival of allografts in
recipients possible.
• Rejection of allografts involves both cell-
mediated and humoral immunity.
11. 1. CELL-MEDIATED IMMUNE REACTIONS
• Mainly responsible for graft rejection and are
mediated by T cells (mainly by cytotoxic T
cells).
• T cells attack the graft and destroy it.
12. 2. HUMORAL IMMUNE REACTIONS
• In addition to the cell-mediated immune
reactions, humoral antibodies cause certain
rejection reactions.
13. TYPES OF REJECTION REACTIONS
• Based on the underlying mechanism and time
period, rejection reactions are classified into 3
types:
1- Hyperacute Rejection
2- Acute Rejection
3- Chronic Rejection
14. 1. HYPERACUTE REJECTION
• Hyperacute rejection appears within minutes
to hours of placing the transplant and
destroys it.
• It is mediated by Humoral system antibodies.
• This type of rejection is seen when a recipient
is given the wrong type of blood.
• For example, when a person is given type A
blood when he or she is type B.
15. 2. ACUTE REJECTION
• This usually becomes evident within a few
days to a few months of transplantation.
• Acute graft rejection may be mediated by
cellular or humoral mechanisms.
16. 3. CHRONIC REJECTION
• Chronic rejection may develop slowly over a
period of months to a year or so.
• The underlying mechanisms of chronic
rejection may be immunologic or ischaemic.
• Patients with chronic rejection of renal
transplant show progressive deterioration in
renal function as seen by rising serum
creatinine levels.
17. How to overcome transplant rejection?
• Tissue typing is done to prevent transplant rejection
• Here both the organ donor and the person who is
receiving the organ tissue typing is done to ensure that
the organ or tissue is as similar as possible to the
tissues of the recipient.
• The more similar the antigens are between the donor
and recipient, the less likely that the organ will be
rejected.
• No match is usually 100 percent identical.
• No two people, except identical twins, have identical
tissue antigens.